The efficacy of prophylactic tamsulosin in preventing acute urinary retention after benign anorectal surgeries

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190115042363N1

Enrollment

140

Registered

2019-04-21

Start date

2018-07-06

Completion date

Unknown

Last updated

2019-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhoid. Hemorrhoids and perianal venous thrombosis

Interventions

Intervention 1: Intervention group: Patients who received tamsulosin at a dose of 0.4 mg 12 hours before surgery. Intervention 2: Control group: Patients who received placebo 12 hours before surgery.

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Both sexes 20 to 70 years Indication of hemorrhoidectomy and fistulotomy and sphincterotomy IPSS criteria less than 7

Exclusion criteria

Exclusion criteria: Urinary tract infection History of neurological disorder Malignancy Urinary incontinence Use of medications that affect urination History of drug allergy to tamsulosin Recent Tamsulosin Uses

Design outcomes

Primary

Measure	Time frame
Urinary retention. Timepoint: 24 hours after surgery. Method of measurement: Clinical response.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad naeem bangash

Zanjan University of Medical Sciences

gps1376@yahoo.com+98 24 3313 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026